Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Astrocytoma, Grade IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01280552
What this trial is testing

ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma Multiforme
Precision Life Sciences Group 124
Early research (Phase 1)Study completedNCT01222221
What this trial is testing

Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Cancer Research UK 45
Testing effectiveness (Phase 2)Study completedNCT02799238
What this trial is testing

Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma

Who this might be right for
Glioblastoma
CytoVac A/S 62
Large-scale testing (Phase 3)UnknownNCT03008148
What this trial is testing

Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM

Who this might be right for
Glioblastoma
Johnpro Biotech, Inc. 288
Testing effectiveness (Phase 2)Looking for participantsNCT06936046
What this trial is testing

Enhanced Adjuvant Therapy for Newly Diagnosed GBM With Partial Surgical Resection or Short-term Progression

Who this might be right for
Glioblastoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT04019262
What this trial is testing

Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
John Flickinger 2
Early research (Phase 1)Active Not RecruitingNCT05743595
What this trial is testing

Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma

Who this might be right for
Unmethylated Glioblastoma
Washington University School of Medicine 27
Testing effectiveness (Phase 2)Looking for participantsNCT07346144
What this trial is testing

Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma

Who this might be right for
Glioblastoma (GBM)High Grade GliomasRecurrent Glioblastoma+1 more
Trogenix ltd 68
Early research (Phase 1)Looking for participantsNCT07143812
What this trial is testing

Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma (GBM)Newly Diagnosed Glioblastoma Multiforme
CHA University 10
Testing effectiveness (Phase 2)Study completedNCT00720356
What this trial is testing

Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Brain and Central Nervous System Tumors
Northwestern University 115
Testing effectiveness (Phase 2)Study completedNCT00124657
What this trial is testing

Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma

Who this might be right for
Brain and Central Nervous System Tumors
St. Jude Children's Research Hospital 62
Large-scale testing (Phase 3)Study completedNCT00482677
What this trial is testing

Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Canadian Cancer Trials Group 562
Testing effectiveness (Phase 2)Looking for participantsNCT03213002
What this trial is testing

Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

Who this might be right for
Glioblastoma Multiforme (GBM)GlioblastomaGlioma of Brain+6 more
Northwell Health 67
Not applicableEnded earlyNCT00430079
What this trial is testing

Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+11 more
National Cancer Institute (NCI) 48
Early research (Phase 1)Active Not RecruitingNCT04978727
What this trial is testing

A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma

Who this might be right for
MedulloblastomaGlioblastoma MultiformeAnaplastic Astrocytoma+5 more
Children's Oncology Group 35
Testing effectiveness (Phase 2)UnknownNCT05033587
What this trial is testing

Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma.

Who this might be right for
MGMT-Unmethylated Glioblastoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 28
Early research (Phase 1)Study completedNCT00770471
What this trial is testing

ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 24
Large-scale testing (Phase 3)Study completedNCT03776071
What this trial is testing

A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1

Who this might be right for
Glioblastoma
Denovo Biopharma LLC 260
Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Early research (Phase 1)Active Not RecruitingNCT04165941
What this trial is testing

Novel Gamma-Delta (γδ)T Cell Therapy for Treatment of Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Brain Tumor Adult
University of Alabama at Birmingham 22
Next Page